Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BVS NASDAQ:EMBC NASDAQ:INMD NASDAQ:SSII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$10.68+5.0%$9.23$5.81▼$10.76$845.68M0.72446,968 shs507,668 shsEMBCEmbecta$3.90-57.8%$9.12$3.89▼$15.55$547.78M1.09689,670 shs16.02 million shsINMDInMode$14.40+0.6%$13.83$12.72▼$16.74$906.66M1.97617,672 shs580,932 shsSSIISS Innovations International$3.90-3.7%$4.71$3.02▼$11.87$810.94MN/A46,024 shs36,150 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus+5.64%+7.23%+19.06%+31.85%+1,067,999,900.00%EMBCEmbecta-57.75%-56.81%-55.93%-65.64%-68.70%INMDInMode-0.07%+1.34%+4.42%-4.13%+1.05%SSIISS Innovations International-2.26%-9.51%-22.00%+0.26%+389,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBVSBioventus$10.68+5.0%$9.23$5.81▼$10.76$845.68M0.72446,968 shs507,668 shsEMBCEmbecta$3.90-57.8%$9.12$3.89▼$15.55$547.78M1.09689,670 shs16.02 million shsINMDInMode$14.40+0.6%$13.83$12.72▼$16.74$906.66M1.97617,672 shs580,932 shsSSIISS Innovations International$3.90-3.7%$4.71$3.02▼$11.87$810.94MN/A46,024 shs36,150 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBVSBioventus+5.64%+7.23%+19.06%+31.85%+1,067,999,900.00%EMBCEmbecta-57.75%-56.81%-55.93%-65.64%-68.70%INMDInMode-0.07%+1.34%+4.42%-4.13%+1.05%SSIISS Innovations International-2.26%-9.51%-22.00%+0.26%+389,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBVSBioventus 3.00Buy$14.0031.09% UpsideEMBCEmbecta 2.00Hold$18.50374.36% UpsideINMDInMode 2.00Hold$17.2519.79% UpsideSSIISS Innovations International 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest EMBC, INMD, BVS, and SSII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2026EMBCEmbecta BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral4/21/2026SSIISS Innovations International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/13/2026EMBCEmbecta MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$14.00 ➝ $12.003/27/2026BVSBioventus CJS SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageMarket Outperform$14.003/6/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$13.00 ➝ $14.003/6/2026BVSBioventus Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$15.00 ➝ $16.003/4/2026BVSBioventus Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy2/11/2026INMDInMode Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$17.002/9/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy2/9/2026BVSBioventus Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$13.002/6/2026EMBCEmbecta BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$25.00(Data available from 5/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBVSBioventus$568.09M1.56$1.34 per share7.97$2.76 per share3.87EMBCEmbecta$1.08B0.21$1.69 per share2.31($11.12) per share-0.35INMDInMode$370.49M2.46$1.50 per share9.59$10.78 per share1.34SSIISS Innovations International$42.49M18.38N/AN/A$0.20 per share19.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBVSBioventus$22.73M$0.3332.3612.42N/A4.00%28.88%8.53%N/AEMBCEmbecta$95.40M$2.371.651.36N/A12.92%-26.66%16.06%5/5/2026 (Estimated)INMDInMode$93.83M$1.4410.00N/AN/A25.33%14.52%12.88%5/6/2026 (Estimated)SSIISS Innovations International-$12.13M-$0.06N/AN/AN/A-28.54%-30.23%-17.50%N/ALatest EMBC, INMD, BVS, and SSII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2026Q1 2026INMDInMode$0.2974N/AN/AN/A$79.84 millionN/A5/5/2026Q2 2026EMBCEmbecta$0.42$0.27-$0.15-$0.07$235.67 million$221.80 million3/10/2026Q4 2025SSIISS Innovations InternationalN/A-$0.01N/A-$0.01N/A$14.53 million3/5/2026Q4 2025BVSBioventus$0.22$0.24+$0.02$0.21N/A$157.90 million2/10/2026Q4 2025INMDInMode$0.4167$0.46+$0.0433$0.42$104.64 million$103.85 million2/5/2026Q1 2026EMBCEmbecta$0.67$0.71+$0.04$0.74$258.07 million$261.20 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBVSBioventusN/AN/AN/AN/AN/AEMBCEmbecta$0.6014.83%N/A25.32%N/AINMDInModeN/AN/AN/AN/AN/ASSIISS Innovations InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBVSBioventus1.221.701.19EMBCEmbectaN/A2.641.87INMDInModeN/A9.888.83SSIISS Innovations InternationalN/A1.861.21Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBVSBioventus62.94%EMBCEmbecta93.83%INMDInMode68.04%SSIISS Innovations InternationalN/AInsider OwnershipCompanyInsider OwnershipBVSBioventus33.00%EMBCEmbecta1.30%INMDInMode6.92%SSIISS Innovations InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBVSBioventus1,20083.15 million55.71 millionN/AEMBCEmbecta1,85059.22 million58.45 millionOptionableINMDInMode48063.36 million58.98 millionOptionableSSIISS Innovations International4200.23 millionN/AN/AEMBC, INMD, BVS, and SSII HeadlinesRecent News About These CompaniesSS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic SystemMay 5 at 8:30 AM | globenewswire.comSS Innovations International (NASDAQ:SSII) Downgraded by Wall Street Zen to "Sell"May 2, 2026 | marketbeat.comShort Interest in SS Innovations International, Inc. (NASDAQ:SSII) Declines By 49.8%April 26, 2026 | marketbeat.comSS Innovations Showcases Next-Gen Robotic Surgery Platforms GloballyApril 25, 2026 | theglobeandmail.comPRISM MediaWire – Weekly Press Release Round Up – April 20 to April 24, 2026 – Top Financial & Corporate News HighlightsApril 24, 2026 | prismmediawire.comPSS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026April 23, 2026 | prismmediawire.comPSS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026April 23, 2026 | globenewswire.comSS Innovations International (NASDAQ:SSII) Shares Gap Down - Here's WhyApril 22, 2026 | marketbeat.comSS Innovations International (NASDAQ:SSII) Shares Gap Up - Time to Buy?April 13, 2026 | marketbeat.comSS Innovations: Progress Is Real, But I Still See Limited UpsideApril 9, 2026 | seekingalpha.comSS Innovations International (NASDAQ:SSII) Trading Down 8.2% - Should You Sell?April 8, 2026 | marketbeat.comSS Innovations International (NASDAQ:SSII) Stock Price Up 8.8% - Time to Buy?April 7, 2026 | marketbeat.comSS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026April 7, 2026 | prismmediawire.comPSS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026April 7, 2026 | globenewswire.comSS Innovations International Inc (SSII)April 3, 2026 | nasdaq.comSS Innovations International, Inc. (SSII) gains approvals for SSi Mantra in key emerging marketsApril 3, 2026 | msn.comSS Innovations Is A Compelling Surgical Robotics Growth PlayMarch 30, 2026 | seekingalpha.comSS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and KenyaMarch 30, 2026 | prismmediawire.comPSS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and KenyaMarch 30, 2026 | globenewswire.comWhy SS Innovations (SSII) Is Up 10.8% After Telesurgery Milestone And Auditor Going Concern DoubtsMarch 23, 2026 | finance.yahoo.comSS Innovations’ SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the PhilippinesMarch 18, 2026 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEMBC, INMD, BVS, and SSII Company DescriptionsBioventus NASDAQ:BVS$10.68 +0.51 (+5.01%) Closing price 05/5/2026 04:00 PM EasternExtended Trading$11.03 +0.35 (+3.27%) As of 05/5/2026 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.Embecta NASDAQ:EMBC$3.90 -5.35 (-57.84%) Closing price 05/5/2026 04:00 PM EasternExtended Trading$4.02 +0.12 (+3.18%) As of 05/5/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.InMode NASDAQ:INMD$14.40 +0.09 (+0.63%) Closing price 05/5/2026 04:00 PM EasternExtended Trading$14.48 +0.08 (+0.59%) As of 05/5/2026 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.SS Innovations International NASDAQ:SSII$3.90 -0.15 (-3.70%) Closing price 05/5/2026 04:00 PM EasternExtended Trading$3.93 +0.03 (+0.77%) As of 05/5/2026 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. 3 Reasons Analysts Love DexCom The Great Chip Divide: AI Chip War Pivots from Hype to Execution Atomic Dividends: Big Tech's New Energy Bet Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
